{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-045871","form_type":"8-K","ticker":"KZR","cik":"0001645666","company_name":"Kezar Life Sciences, Inc.","filed_at":"2025-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.031672+00:00","generated_at":"2026-05-17T02:45:59.348134+00:00","sec_items":["1.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Kezar Life Sciences repays $6.3M in full, terminates Loan Agreement with Oxford Finance","bullets":["Repaid $6.3M in full satisfaction of outstanding amount including accrued interest and exit fees.","Loan and Security Agreement dated Nov 4, 2021 terminated; all liens and security interests released.","Repayment made using cash on hand; no new debt incurred."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-045871","json":"https://secwatch.observer/filing/0001628280-25-045871.json","markdown":"https://secwatch.observer/filing/0001628280-25-045871.md","text":"https://secwatch.observer/filing/0001628280-25-045871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645666/000162828025045871/0001628280-25-045871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645666/000162828025045871/kzr-20251020.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:45:59.348134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}